Literature DB >> 20049800

Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents.

Rudolph L Juliano1, Rowshon Alam, Vidula Dixit, Hyun Min Kang.   

Abstract

This review will discuss the basic concepts concerning the use of cell-targeting peptides (CTPs) and cell-penetrating peptides (CPPs) in the context of nanocarrier technology. It deals with the discovery and subsequent evolution of CTPs and CPPs, issues concerning their interactions with cells and their biodistribution in vivo, and their potential advantages and disadvantages as delivery agents. The article also briefly discusses several specific examples of the use of CTPs or CPPs to assist in the delivery of nanoparticles, liposomes, and other nanocarriers. 2009 John Wiley & Sons, Inc.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20049800     DOI： 10.1002/wnan.4

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol        ISSN： 1939-0041


  26 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

2.  The optimization of polymalic acid peptide copolymers for endosomolytic drug delivery.

Authors:  Hui Ding; Jose Portilla-Arias; Rameshwar Patil; Keith L Black; Julia Y Ljubimova; Eggehard Holler
Journal:  Biomaterials       Date:  2011-04-22       Impact factor: 12.479

Review 3.  Clinical developments in nanotechnology for cancer therapy.

Authors:  Jeremy D Heidel; Mark E Davis
Journal:  Pharm Res       Date:  2010-06-12       Impact factor: 4.200

Review 4.  Signed, Sealed, Delivered: Conjugate and Prodrug Strategies as Targeted Delivery Vectors for Antibiotics.

Authors:  Ana V Cheng; William M Wuest
Journal:  ACS Infect Dis       Date:  2019-04-10       Impact factor: 5.084

5.  Protective effects of anti-ricin A-chain antibodies delivered intracellularly against ricin-induced cytotoxicity.

Authors:  Feng Wu; Shaoan Fan; Frank Martiniuk; Seth Pincus; Sybille Müller; Heinz Kohler; Kam-Meng Tchou-Wong
Journal:  World J Biol Chem       Date:  2010-05-26

6.  p53 is an important regulator of CCL2 gene expression.

Authors:  X Tang; M Asano; A O'Reilly; A Farquhar; Y Yang; S Amar
Journal:  Curr Mol Med       Date:  2012-09       Impact factor: 2.222

7.  Advances in targeted nanotherapeutics: From bioconjugation to biomimicry.

Authors:  Danielle M Valcourt; Jenna Harris; Rachel S Riley; Megan Dang; Jianxin Wang; Emily S Day
Journal:  Nano Res       Date:  2018-05-17       Impact factor: 8.897

Review 8.  High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists.

Authors:  Bainan Wu; Elisa Barile; Surya K De; Jun Wei; Angela Purves; Maurizio Pellecchia
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

Review 9.  Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides.

Authors:  Rudolph L Juliano; Xin Ming; Osamu Nakagawa
Journal:  Bioconjug Chem       Date:  2011-10-27       Impact factor: 4.774

10.  Selecting improved peptidyl motifs for cytosolic delivery of disparate protein and nanoparticle materials.

Authors:  Kelly Boeneman; James B Delehanty; Juan B Blanco-Canosa; Kimihiro Susumu; Michael H Stewart; Eunkeu Oh; Alan L Huston; Glyn Dawson; Sampat Ingale; Ryan Walters; Miriam Domowicz; Jeffrey R Deschamps; W Russ Algar; Stassi Dimaggio; Janet Manono; Christopher M Spillmann; Darren Thompson; Travis L Jennings; Philip E Dawson; Igor L Medintz
Journal:  ACS Nano       Date:  2013-05-28       Impact factor: 15.881
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.